|
HS Code |
462452 |
| Chemical Name | 2-Butyl-1-Bromooctane |
| Molecular Formula | C12H25Br |
| Molecular Weight | 265.23 g/mol |
| Cas Number | 66744-81-6 |
| Appearance | Colorless to pale yellow liquid |
| Boiling Point | 260-265°C |
| Density | 1.05 g/cm3 |
| Refractive Index | 1.457-1.462 |
| Flash Point | 113°C |
| Purity | Typically ≥ 97% |
| Solubility | Insoluble in water; soluble in organic solvents |
| Storage Conditions | Store in a cool, dry place and keep container tightly closed |
As an accredited 2-Butyl-1-Bromooctane factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | |
| Shipping | |
| Storage |
Competitive 2-Butyl-1-Bromooctane prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
2-Butyl-1-bromooctane strikes a chord with those who work in organic synthesis, fine chemistry projects, and specialty research settings. Its structure—featuring a bromine atom bonded at one end of an octane chain, capped off with a butyl group down the carbon spine—lends itself to an array of transformations. Never flashy or headline-grabbing, this molecule quietly powers along as a workhorse in chemical rooms and scale-up facilities. I remember early in my career watching a batch operation deploy 2-butyl-1-bromooctane as a step in synthesizing custom-designed surfactants. The sense of practicality and reliability stood out; here was a molecule that did its job, delivered solid yields, and handled with a certain predictability seasoned chemists learn to appreciate.
A lot of alkyl bromides fill catalogs, so it’s natural to ask why 2-butyl-1-bromooctane deserves a closer look. The branching at the “2-butyl” position makes a real impact. Chemical reactivity shifts once branching steps in—sterically, branched intermediates behave differently compared to their straight-chain relatives. This matters when tackling substitution or elimination reactions, where too much branching can block unwanted side reactions or support desired selectivity. Anyone who’s ever tried to push a stubborn alkyl group into a target molecule, only to end up with a mess of isomers, knows the headache. Something as subtle as a butyl branch does a lot to clean up the final product. This fact isn’t just theory; it shows up in actual reaction mixtures on the bench.
Another feature rarely discussed in marketing blurbs is how the bromo group at the terminal position influences the pathway for nucleophilic substitution. Alkyl bromides sit closer to the sweet spot of reactivity than chlorides or iodides: more reactive than chloro-derivatives yet more stable and practical than iodoalkanes, which often come with a bigger safety and handling burden. In a field where every variable—temperature, solvent, stirring speed—can shift an outcome, the confident behavior of bromooctanes brings a small but persistent advantage.
Talking to operators and chemists, you hear about the headaches caused by small impurities and water content with many halogenated reagents. 2-Butyl-1-bromooctane proves its value with its stability profile and purity record. In my direct experience, purity levels above 98% are crucial for consistent downstream results, especially in sensitive syntheses involving pharmaceuticals or specialty polymers. Even minor contaminants in the starting halide can end up as persistent residues, showing up in spectral analysis and sometimes ruining months of development work. The best samples of 2-butyl-1-bromooctane often come as colorless or pale straw liquids, faintly aromatic but generally low odor. Storage in amber bottles—preferably under inert gases—keeps the material fresh, and regular GC checks help confirm that nothing has degraded or hydrolyzed.
The boiling and melting range rarely becomes an issue unless someone is pushing process windows or looking to distill on site. In practical use, 2-butyl-1-bromooctane typically remains a stable liquid well under normal reaction conditions, which simplifies handling and dosing—no fuss, no troublesome crystallization. I’ve seen this appreciated most in mid-volume production, where flow can become disrupted by sticky solids or freezing points too close to room temperature.
The putative reactions using 2-butyl-1-bromooctane span Suzuki couplings, Williamson ether synthesis, and Grignard reagent formation. For those seeking to alkylate complex molecules—sometimes peptides, sometimes custom ligands—the route often follows the same story: start with a robust alkyl halide to lay down a confident backbone, then build complexity stepwise. I can recall a cross-coupling protocol where using straight-chain 1-bromooctane led to undesirable side-chain rearrangements. Swapping in 2-butyl-1-bromooctane suppressed the issue, letting the main product dominate. The lesson is simple—branching impacts final outcomes, and thoughtful reagent selection saves time and raw materials.
Grignard formation provides another good case. Magnesium turnings, dry ether, and the right bromide yield a heavy, reactive Grignard. Straight-chain analogs often react too fast or with less control, leading to side reactions that consume yield. The branched 2-butyl variant slows things just enough, providing time for careful observation and course correction if something begins to run off track. Anyone with scars from runaway Grignards knows the value of steady, controlled vigor over uncontrolled flash.
One key difference comes from the balance between reactivity and selectivity. Straight-chain alkyl bromides can be a blunt tool—reactive, but undisciplined in their impact on molecular targets. Drop a methyl or butyl branch onto the chain, and that blunt edge sharpens. Steric hindrance becomes an ally, steering reactions to more desirable positions or lowering the odds that an eager nucleophile attacks vulnerable, but unwanted, sites. This is subtle chemistry, not often captured by catalogs or summaries, but it’s the sort of detail that becomes obvious when faced with problem-solving under pressure.
Colleagues in specialty chemical manufacturing talk often about scalability. Small differences in side-chain structure can ripple out into process reliability, impurity profiles, and environmental impact. 2-Butyl-1-bromooctane may seem like just another halide, but the right branching pattern tends to ease demands on purification steps downstream. Money gets saved on solvent, time, and troubleshooting. Less waste results, and batch-to-batch reproducibility improves. In synthesis support roles, I have seen requests for this specific molecule jump whenever rigorous project timelines intersect with short-staffed analytical teams—nobody wants last-minute troubleshooting when the project goal is clear and the deadline is moving closer.
Isomeric purity matters here, especially since some isomer families bring side effects—unexpected boiling points, separations nightmares, or volatility, which can affect worker safety or environmental compliance. 2-butyl-1-bromooctane usually comes as a single constitutional isomer, minimizing complications. This clarity beats the unpredictable landscapes posed by mixed halide batches or those made by too-loose synthesis protocols.
Most early applications emerged in the preparation of custom surfactants and specialty lubricants, settings where fine-tuning solubility, viscosity, or chemical compatibility meant real money for the customer. The NMR results—the little peaks and integrals—reflected choices made with the help of 2-butyl-1-bromooctane as a reliable anchor. Over time, applications expanded. Custom ligands for metal complexes, initiators in radical chemistry, and key steps in macrocyclic compound assembly all called for the unique attributes of this molecule.
More recently, conversations with pharmaceutical process engineers have revealed another layer. Branching in side chains can change the metabolic stability of a potential drug candidate. Choice of starting halide, even at what looks like an early, inconsequential step, reaches through to later ADME (absorption, distribution, metabolism, excretion) studies. 2-Butyl-1-bromooctane carries with it just enough bulk and shape to subtly adjust the fate of the final compound. This realization leads to design choices that trim years off development time, preventing expensive failures when scaled formulations hit regulatory and efficacy hurdles.
Years spent with liquid handling systems and glassware have built a real respect for nuanced reagent selection. Alkyl bromides like 2-butyl-1-bromooctane demonstrate over and over that engineering “know-how” begins in the molecular structure drawn out on the page. Every shortcut, every time-saver in scale-up, gets traced back to an informed decision on structure and purity. I have been in meetings where managers wondered why previous projects ran long or budgets swelled; often someone would point to batches doomed by early-stage impurity, poor reactivity, or unexpected byproducts. Chemists with experience will share that molecules like 2-butyl-1-bromooctane became project favorites because they cut down on unforeseeable snags.
Handling and storage pose little challenge, provided one avoids excess moisture and exposure to light. Most well-run facilities use sealed pumps or nitrogen-blanketed containers to move and hold alkyl bromides. Simple, affordable, and manageable, 2-butyl-1-bromooctane sees use in pilot plants and kilo-labs as well as academic research. Picking a reagent that can cross between these worlds adds practical efficiency—one less procurement change to request, one less list of hazards to re-investigate.
No chemical comes without its quirks. Brominated organics have a reputation for environmental persistence if accidentally spilled or mismanaged. Systems that rely too heavily on open transfer risk operator exposure as well as broader environmental release. Facilities that take the extra care to invest in closed handling, local fume extraction, and spill control not only follow best practice but also protect their people and company reputation. Another recurring challenge: ensuring every batch matches analytical benchmarks. Chromatography and NMR remain reliable tools here. Once, I watched a project stall when a single impurity, invisible in low-resolution analysis, accumulated over several batches and confused the downstream process. The fix called for implementing more stringent lot-release testing—not expensive, but easy to overlook when caught up in production schedules.
Another issue, not often discussed openly but seen in day-to-day work, is the pricing volatility tied to bromine feedstock availability. Changes in global supply chains have more than once forced process chemists to revisit sourcing, even reconsidering whether to risk switching to a less-favored halide if lead times became impossible. Long-term relationships with reliable suppliers, coupled with honest forecasting and flexibility in order sizes, have softened these impacts. Many small labs have trouble weathering sudden price spikes, whereas larger outfits may have buffers in licensing or procurement agreements. On this front, honest, up-to-date communication between purchasing and technical teams prevents a lot of last-minute headaches.
Anyone working in industry today knows the pressure to clean up process chemistry. While 2-butyl-1-bromooctane stands much less problematic than some halogenated cousins, wider adoption of greener chemistry means users need to find ways to recover and destroy or recycle brominated waste. I’ve watched teams install improved separation systems and small-scale incinerators just to handle side products. Those willing to invest upfront in reclamation often enjoy smoother regulatory approvals and reduced emissions. For labs aiming to stay ahead of the sustainability curve, exploring biocatalytic routes that skip brominated intermediates entirely illustrates a forward-thinking mindset. Still, for a significant portion of current needs, especially when selectivity and yield cannot afford compromise, 2-butyl-1-bromooctane remains difficult to replace without adding complexity.
In pharmaceutical and chemical development, making decisions about intermediates isn’t just a matter of checking a box on a reagent list. Teams lean heavily on trusted data—physical properties, analytical spectra, and reported outcome consistency. Organic chemistry reminds us that a single unexpected impurity or a missed spectroscopic detail sometimes throws an entire project off track, especially in regulatory environments. The more transparent and complete reporting that accompanies batches of 2-butyl-1-bromooctane, the smoother the path for end-users who need to defend their process in front of QA teams or regulatory inspectors. As someone who’s sat across from compliance officers, I can vouch for the peace of mind that a full, high-quality certificate of analysis brings.
A well-characterized lot of 2-butyl-1-bromooctane isn’t just a commodity; it’s an investment in clear processes and shared scientific understanding. Those working with new team members or training staff sharpen their skills not just by working through safe handling routines, but also by understanding why branched halides like this often outperform alternatives. Real progress in chemical manufacturing often comes not from revolutionary new molecules, but from ever-better mastery of familiar intermediates.
Several academic groups now take extra steps to publish details about starting halides, reaction run histories, and purification parameters. This open sharing, rooted in both reproducibility and shared learning, sets a higher standard and helps everyone in the ecosystem sidestep redundant mistakes. As research moves forward, and project stakes climb higher—whether through regulatory scrutiny or rising demand—having a well-established track record with intermediates like 2-butyl-1-bromooctane means fewer costly surprises for researchers and teams alike.
The landscape for specialty organics and reagents keeps shifting. New discoveries, regulatory shifts, and novel catalysis methods all weigh on what’s possible for intermediate selection. In practice, though, the steady, reliable performance of well-characterized compounds like 2-butyl-1-bromooctane holds enduring appeal. People look for flexibility and reliability—qualities that are hard to quantify but easy to recognize when projects stay on schedule, waste drops, and upsets grow rare. Staff resourcefulness and deep experience amplify this effect, using the accumulated lessons of each synthesis run to improve the next one.
Looking ahead, the search for greener routes may gradually replace brominated intermediates entirely in some lines of work. For now, carefully managed use, strong sourcing relationships, and a culture of transparency allow products like 2-butyl-1-bromooctane to keep supporting innovation without dragging down progress with unnecessary risks. Batch after batch, day after day, it’s often the solid, workmanlike performance of well-chosen reagents that makes breakthroughs and discoveries actually happen. Learning to recognize and value this steady support is what turns budding chemists into seasoned professionals. The lessons never really end; the chemistry keeps unfolding, and strong, reliable tools keep making pursuit of better science possible.